Moreover, the role of recent biomarkers including NLRP3 inflammasome and its downstream cytokines including IL-1β in the pathogenesis of metabolic syndrome as well as its comorbid diseases are warranted. The gene discussed is IL1B; the disease is metabolic syndrome.